Investigating the therapeutic potential of cannabinoids in pre-clinical models of migraine
Iowa Research Online (The University of Iowa) · 09.12.2024
DOI: 10.25820/etd.007600 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iowa Research Online (The University of Iowa), erschienen am 09.12.2024. Verfasst von Erik Zorrilla.
Abstract (Originalsprache)
Migraine is a complex and debilitating neurological condition with significant social and economic consequences worldwide. Although recent advances in treatments such as CGRP monoclonal antibodies and triptans have improved care for some, many migraine patients continue to experience insufficient relief, side effects, or dissatisfaction with current options. This unmet need highlights the urgency for alternative treatments. Cannabinoids, specifically CBD and THC, have gained attention as promising candidates due to their anti-inflammatory and analgesic properties, as well as their interactions with the trigeminovascular system, a key player in migraine pathophysiology. This thesis investigates the potential of cannabinoids to alleviate migraine symptoms, focusing on their efficacy and safety.
Schlagwörter
Zitieren
APA
Zorrilla, E. (2024). Investigating the therapeutic potential of cannabinoids in pre-clinical models of migraine. Iowa Research Online (The University of Iowa). https://doi.org/10.25820/etd.007600
Vancouver
Zorrilla E. Investigating the therapeutic potential of cannabinoids in pre-clinical models of migraine. Iowa Research Online (The University of Iowa). 2024. doi:10.25820/etd.007600
BibTeX
@article{Zorrilla2024,
author = {Zorrilla, Erik},
title = {Investigating the therapeutic potential of cannabinoids in pre-clinical models of migraine},
journal = {Iowa Research Online (The University of Iowa)},
year = {2024},
doi = {10.25820/etd.007600}
}
EUVIMED